New Zealand Gazette – 1992 – No. 179

Page 3729

✨ Health and Agriculture Notices



5 NOVEMBER NEW ZEALAND GAZETTE 3729

Any damage in this category has to be relatively noticeable. Fruit should be free from any defects to be relatively noticeable.

  • Surface russetting, defined as any brown blemish or brown mark on the berry. Up to an aggregate area of 2 square millimetres is acceptable.
  • Torn scars, a small tear is acceptable, large tears exposing the flesh are unacceptable.
  • Bruised fruit/wet fruit that is soft, and weeping is unacceptable.
  • Fruit wet from juice is unacceptable.

Colour:

Fruit must be a uniform blue in accordance with the varietal characteristics.

A maximum of 20 percent of red/purple of the berry is allowable.

The variety Delite is exempt from the above. This variety is acceptable with a purple/blue hue colour over all the berry. It must not be bright red obviously immature.

Cap Stems:

All cap stems to be removed.

Clusters:

These are not to be present.

Maturity:

Overmature must not be present.
Undermature must not be present.

Dated at Wellington this 29th day of October 1992.

R. BALLARD, Director-General, Ministry of Agriculture and Fisheries.

  • S.R. 1975/57

General Information

These requirements are not part of this notice but are to be met in order to facilitate export certification.

  1. Each tray must bear the following particulars in letters legibly and indelibly marked and visible from the outside:

    • Growers Identification Number:
    • Product Type:
    • Grade:
    • Country of Origin:
    • Net Weight.

  2. Each punnet must have the following:

    • Net weight in ounces or grams depending on the market;
    • and brand name.

  3. The blueberries must be packed in such a way as to ensure that they are suitably protected.

Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Beclomethasone dipropionate Oral aerosol Orion Corporation Limited, Espoo, Finland Atomide Junior Inhaler
50 mcg per dose
Beclomethasone dipropionate Oral aerosol Orion Corporation Limited, Espoo, Finland Atomide Forte Inhaler
250 mcg per dose
Diclofenac sodium 100 mg Tablets Euderma Srl, Cerasolo di Coriano, Italy, or Valpharma SA Serravalle, Republic of San Marino Diclax SR

Dated this 30th day of October 1992.

C. LOVEACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Remoxipride hydrochloride monohydrate Capsules Astra Pharmaceutical Production AB, Södertälje, Sweden Roxiam
75 mg, 150 mg, 300 mg
Remoxipride hydrochloride monohydrate Controlled release capsules Astra Pharmaceutical Production AB, Södertälje, Sweden Roxiam
150 mg, 300 mg
Remoxipride hydrochloride monohydrate Oral suspension Astra Pharmaceutical Production AB, Södertälje, Sweden Roxiam
25 mg/ml


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa — PDF NZ Gazette 1992, No 179


NZLII — PDF NZ Gazette 1992, No 179




✨ LLM interpretation of page content

🌾 Standard Grade for the Export of Fresh Blueberries (continued from previous page)

🌾 Primary Industries & Resources
29 October 1992
Blueberries, Export, Standard Grade, Fruit Quality, Packaging, Sizing
  • R. Ballard, Director-General, Ministry of Agriculture and Fisheries

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
30 October 1992
Medicines, Distribution, Beclomethasone dipropionate, Diclofenac sodium
  • C. Loveace, Director-General of Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
30 October 1992
Medicines, Distribution, Remoxipride hydrochloride monohydrate
  • C. Loveace, Director-General of Health